title: How I do it: percutaneous radiofrequency ablation (RFA).
abstract: Percutaneous radiofrequency ablation has seen increased utilization secondary to the rising incidence of renal cell carcinoma. This has been shown to be an effective and durable treatment especially in the elderly comorbid patient. In this article, we describe our technique and factors related to successful outcomes.
authors.affiliation: Department of Urology, UT Southwestern Medical Center, Dallas, Texas, USA.
authors.forename: Igor
authors.initials: I
authors.lastname: Sorokin
authors.forename: Murthy
authors.initials: M
authors.lastname: Chamarthy
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Cadeddu
mesh_terms: D002292:Carcinoma, Renal Cell / Q000000981:diagnostic imaging / Q000601:surgery*; D017115:Catheter Ablation / Q000379:methods*; D003287:Contrast Media; D006801:Humans; D007680:Kidney Neoplasms / Q000000981:diagnostic imaging / Q000601:surgery*; D056888:Patient Positioning; D018579:Patient Selection; D011300:Preoperative Care; D000078702:Radiofrequency Therapy; D014057:Tomography, X-Ray Computed
chemical_list: D003287:Contrast Media